)

Chase Paul Monckton
Analytical Development Scientist II,
Excellos
A scientist in the cell and gene therapy space, Chase Monckton specializes in developing engineering solutions that bridge discovery to delivery. With expertise in designing and implementing advanced preclinical screening platforms, Chase focuses on accelerating the translation of novel therapies into scalable, GMP-compliant manufacturing processes. Chase has worked extensively with industry and academic partners to address critical challenges in process development, technology transfer, and regulatory readiness. By combining a deep understanding of cell biology with a pragmatic approach to manufacturing, Chase helps enable the successful progression of cell-based therapies from the lab bench into clinical trials and commercial markets.